propranolol has been researched along with Cirrhosis in 12 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment of rats with the beta-adrenergic agonist isoproterenol results in cardiac hypertrophy, myocyte necrosis, and interstitial cell fibrosis." | 7.67 | Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. ( Benjamin, IJ; Cho, K; Clark, WA; Jalil, JE; Tan, LB; Weber, KT, 1989) |
| "The effects of propranolol and atenolol were investigated on arterial hypertension, cardiomyocyte hypertrophy, and ventricular ischaemic lesions induced by an 8-week treatment with the nitric oxide synthase inhibitor N(omega)-nitro-L-arginine methyl ester (L-NAME; 20 mg/rat per day) in Wistar rats." | 3.71 | Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis. ( Antunes, E; de Azevedo, AP; De Luca, IM; De Nucci, G; De Oliveira, CF; Pacca, SR, 2002) |
| "Treatment of rats with the beta-adrenergic agonist isoproterenol results in cardiac hypertrophy, myocyte necrosis, and interstitial cell fibrosis." | 3.67 | Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. ( Benjamin, IJ; Cho, K; Clark, WA; Jalil, JE; Tan, LB; Weber, KT, 1989) |
| "Carvedilol appears to be a potentially viable option for treating portal hypertension." | 2.42 | Evaluation of carvedilol for the treatment of portal hypertension. ( Hemstreet, BA, 2004) |
| "The BO-induced atrial remodeling was associated with increased calmodulin kinase II-mediated ryanodine receptor 2 phosphorylation on serine 2814, as well as inhibition of Akt phosphorylation." | 1.56 | Effects of occlusal disharmony on susceptibility to atrial fibrillation in mice. ( Hayakawa, Y; Ito, A; Matsuo, I; Mototani, Y; Nariyama, M; Ohnuki, Y; Okumura, S; Saeki, Y; Suita, K; Umeki, D; Yagisawa, Y, 2020) |
| "Pretreatment with propranolol and metoprolol improved survival to 90% and 100% respectively, compared with 60% in the ISO group, but did not reduce the incidence and extent of akinesis or the structural damage." | 1.40 | Functional and histological assessment of an experimental model of Takotsubo's cardiomyopathy. ( Dai, W; Kloner, RA; Sachdeva, J, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Freiha, M | 1 |
| Achim, M | 1 |
| Gheban, BA | 1 |
| Moldovan, R | 1 |
| Filip, GA | 1 |
| Suita, K | 1 |
| Yagisawa, Y | 1 |
| Ohnuki, Y | 1 |
| Umeki, D | 1 |
| Nariyama, M | 1 |
| Ito, A | 1 |
| Hayakawa, Y | 1 |
| Matsuo, I | 1 |
| Mototani, Y | 1 |
| Saeki, Y | 1 |
| Okumura, S | 1 |
| Sachdeva, J | 1 |
| Dai, W | 1 |
| Kloner, RA | 1 |
| Kalambokis, GN | 1 |
| Christodoulou, D | 1 |
| Baltayiannis, G | 1 |
| Christou, L | 1 |
| Hemstreet, BA | 1 |
| Perlini, S | 1 |
| Palladini, G | 1 |
| Ferrero, I | 1 |
| Tozzi, R | 1 |
| Fallarini, S | 1 |
| Facoetti, A | 1 |
| Nano, R | 1 |
| Clari, F | 1 |
| Busca, G | 1 |
| Fogari, R | 1 |
| Ferrari, AU | 1 |
| Ziegelhöffer-Mihalovicova, B | 1 |
| Arnold, N | 1 |
| Marx, G | 1 |
| Tannapfel, A | 1 |
| Zimmer, HG | 1 |
| Rassler, B | 1 |
| Seng, LK | 1 |
| Mahadaven, M | 1 |
| Musa, A | 1 |
| Pacca, SR | 1 |
| de Azevedo, AP | 1 |
| De Oliveira, CF | 1 |
| De Luca, IM | 1 |
| De Nucci, G | 1 |
| Antunes, E | 1 |
| Müller, R | 1 |
| Weller, P | 1 |
| Chemaissani, A | 1 |
| Littmann, L | 1 |
| Svenson, RH | 1 |
| Tomcsanyi, I | 1 |
| Hehrlein, C | 1 |
| Gallagher, JJ | 1 |
| Bharati, S | 1 |
| Lev, M | 1 |
| Splinter, R | 1 |
| Tatsis, GP | 1 |
| Tuntelder, JR | 1 |
| Benjamin, IJ | 1 |
| Jalil, JE | 1 |
| Tan, LB | 1 |
| Cho, K | 1 |
| Weber, KT | 1 |
| Clark, WA | 1 |
1 review available for propranolol and Cirrhosis
| Article | Year |
|---|---|
Evaluation of carvedilol for the treatment of portal hypertension.
Topics: Adrenergic Antagonists; Carbazoles; Carvedilol; Esophageal and Gastric Varices; Fibrosis; Humans; Hy | 2004 |
11 other studies available for propranolol and Cirrhosis
| Article | Year |
|---|---|
In Vivo Study of the Effects of Propranolol, Timolol, and Minoxidil on Burn Wound Healing in Wistar Rats.
Topics: Animals; Antioxidants; Burns; Female; Fibrosis; Inflammation; Minoxidil; Necrosis; Propranolol; Rats | 2023 |
Effects of occlusal disharmony on susceptibility to atrial fibrillation in mice.
Topics: Adrenergic beta-Antagonists; Animals; Apoptosis; Atrial Fibrillation; Atrial Remodeling; Calcium-Cal | 2020 |
Functional and histological assessment of an experimental model of Takotsubo's cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Echo | 2014 |
Propranolol use beyond 6 months increases mortality in patients with Child-Pugh C cirrhosis and ascites.
Topics: Ascites; Child; Fibrosis; Humans; Liver Cirrhosis; Propranolol | 2016 |
Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiomegaly; Co | 2005 |
Effects of salt loading and various therapies on cardiac hypertrophy and fibrosis in young spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Age | 2006 |
Abdominal cocoon: a report of two cases.
Topics: Adolescent; Adult; Female; Fibrosis; Humans; Intestinal Obstruction; Liver Cirrhosis; Male; Proprano | 1993 |
Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressu | 2002 |
[Pleural fibrosis as a side effect of years-long methysergide therapy].
Topics: Biopsy; Cluster Headache; Combined Modality Therapy; Diagnosis, Differential; Endocarditis, Subacute | 1991 |
Modification of atrioventricular node transmission properties by intraoperative neodymium-YAG laser photocoagulation in dogs.
Topics: Animals; Atrioventricular Node; Dogs; Feasibility Studies; Female; Fibrosis; Follow-Up Studies; Hear | 1991 |
Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis.
Topics: Animals; Antibodies, Monoclonal; Autoradiography; Cardiomegaly; DNA; DNA Replication; Fibrosis; Hear | 1989 |